Magnetic Silica-Coated Iron Oxide Nanochains As Photothermal Agents, Disrupting the Extracellular Matrix, and Eradicating Cancer Cells
Overview
Authors
Affiliations
Cancerous cells and the tumor microenvironment are among key elements involved in cancer development, progression, and resistance to treatment. In order to tackle the cells and the extracellular matrix, we herein propose the use of a class of silica-coated iron oxide nanochains, which have superior magnetic responsiveness and can act as efficient photothermal agents. When internalized by different cancer cell lines and normal (non-cancerous) cells, the nanochains are not toxic, as assessed on 2D and 3D cell culture models. Yet, upon irradiation with near infrared light, the nanochains become efficient cytotoxic photothermal agents. Besides, not only do they generate hyperthermia, which effectively eradicates tumor cells in vitro, but they also locally melt the collagen matrix, as we evidence in real-time, using engineered cell sheets with self-secreted extracellular matrix. By simultaneously acting as physical (magnetic and photothermal) effectors and chemical delivery systems, the nanochain-based platforms offer original multimodal possibilities for prospective cancer treatment, affecting both the cells and the extracellular matrix.
Liu Y, Dong S, Hu W, Chen Q, Zhang S, Song K Bioact Mater. 2024; 36:157-167.
PMID: 38463554 PMC: 10924166. DOI: 10.1016/j.bioactmat.2024.02.007.
Influence of Polymer Concentration on Drying of SPION Dispersions by Electrospinning.
Dragar C, Rekar Z, Potrc T, Nemec S, Kralj S, Kocbek P Pharmaceutics. 2023; 15(6).
PMID: 37376067 PMC: 10302812. DOI: 10.3390/pharmaceutics15061619.
Adam A, Mertz D Nanomaterials (Basel). 2023; 13(8).
PMID: 37110927 PMC: 10145772. DOI: 10.3390/nano13081342.
Demin A, Vakhrushev A, Valova M, Korolyova M, Uimin M, Minin A Pharmaceutics. 2022; 14(11).
PMID: 36365090 PMC: 9694706. DOI: 10.3390/pharmaceutics14112271.
Nitica S, Fizesan I, Dudric R, Barbu-Tudoran L, Pop A, Loghin F Biomedicines. 2022; 10(7).
PMID: 35884954 PMC: 9313231. DOI: 10.3390/biomedicines10071647.